The Med-In Pharma 2022 Conference will be taking place between 17 and 18 November 2022 at the Hilton, Malta, and will form part of the Malta Med-Tech World Summit 2022. The Med-In Pharma 2022 Conference will offer the opportunity for discussions on policy-making and regulation, health inquiry, medical innovation, digital health and personalised, patient-focused technology. The Conference promotes best practice and fosters dialogue to ensure innovation can take place in a secure manner that safeguards the public.
Med-In Pharma 2022 is being organized in collaboration with the Faculty of Medicine and Surgery of the University of Malta. The conference will be held over two (2) full days with an audience of approximately two hundred (200) academics, professionals and students and will focus on Innovative Techniques in Medicine, Enabling Technologies, Smart Factory and Future Trends in Pharmacy. The conference will consist of plenary sessions, short communication sessions and poster presentations.
Members of the scientific community practicing in the field of medicine, surgery, dentistry, pharmacy and applied sciences are invited to prepare abstracts related to innovative techniques in medicine, surgery and dentistry enabling technologies, smart factory and future trends in pharmacy and applied sciences for submission to the scientific committee of the Med-In Pharma 2022 Conference.
Abstracts are to be submitted by 26 October 2022. Abstracts will be offered to be presented as a short oral communication or a poster presentation. Authors will be notified on the final results of the review process by 8 November 2022. Accepted abstracts are to be presented by one of the authors who must register for the Malta Med-Tech World Summit 2022
Medical devices and technology are the future of healthcare. I have been at the forefront of this in my surgical career both in Malta and beyond. Cutting-edge technology allowed us to do now what we thought would be impossible before. An ageing population also needs better care, more frequent monitoring, and adequate companionship and technology can bridge the gap that exists in human resources. Through the Malta Medicines Authority, we want to make sure that medical devices and software being introduced in the market are robust, clinically safe and do their intended purpose. We are taking the necessary steps for the Malta Medicines Authority to establish itself as European Competent Authority, excelling in the evaluation and approval of devices. We want Med-Tech World and its side-events to showcase not only innovation but also the strides in device regulation that will ensure that products entering the market make a difference in our lives without causing harm.
Over the years we have built the Malta Medicines Authority as one of the leading regulatory bodies in Europe. We recently have re-affirmed this through regulation of medical cannabis products and looking to increase our presence in the medical device industry. I believe that through conferences such as this, we can increase awareness about what is happening in the industry and can showcase why Malta is becoming a powerhouse in regulation. I also think that a scientific component through the presentation of research is essential, and that is why a scientific poster presentation will feature in Med-In Pharma to allow researches to show their work in an international forum to stimulate innovation.